The DOI matches its Crossref record; 184 of the 185 references it cites were found in a registry or an index.
Apoptosis and necroptosis in the liver: a matter of life and death
Open accessAbstract
Cell death represents a basic biological paradigm that governs outcomes and long-term sequelae in almost every hepatic disease condition. Acute liver failure is characterized by massive loss of parenchymal cells but is usually followed by restitution ad integrum. By contrast, cell death in chronic liver diseases often occurs at a lesser extent but leads to long-term alterations in organ architecture and function, contributing to chronic hepatocyte turnover, the recruitment of immune cells and activation of hepatic stellate cells. These chronic cell death responses contribute to the development of liver fibrosis, cirrhosis and cancer. It has become evident that, besides apoptosis, necroptosis is a highly relevant form of programmed cell death in the liver. Differential activation of specific forms of programmed cell death might not only affect outcomes in liver diseases but also offer novel opportunities for therapeutic intervention. Here, we summarize the underlying molecular mechanisms and open questions about disease-specific activation and roles of programmed cell death forms, their contribution to response signatures and their detection. We focus on the role of apoptosis and necroptosis in acute liver injury, nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH) and liver cancer, and possible translations into clinical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A key feature of MASH is hepatocyte apoptosis, which correlates with the clinically most important feature of the disease, liver fibrosis (6, 7).”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The current study amends this fibrocentric concept by demonstrating fibrosis-independent roles for HSCs through RSPO3, regulating critical parameters that affect CLD progression and outcomes, including metabolic hepatocyte functions, liver regeneration and hepatocyte death2,49,50.”
From Hepatic stellate cells control liver zonation, size and functions via R-spondin 3 (2025) · cites this paper as [50]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Hepatocyte apoptosis is a key feature of metabolic dysfunction–associated steatohepatitis (MASH)”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [6]
In the citing paper
“In NASH, hepatocytes undergo apoptosis, necroptosis or pyroptosis (a newly described caspase 1-dependent apoptosis observed in NASH),33 thereby initiating inflammation in several ways.”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [33]
In the citing paper
“Whilst this process has anti-inflammatory potential, as it removes intracellular content which could otherwise act as DAMPs, efferocytosis also triggers macrophages to release transforming growth factor (TGF)β.”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [33]
In the citing paper
“This signalling pathway positively and negatively modulates inflammation in a number of ways, including via the activation of HSCs, a key source of scar-producing myofibroblasts.33,41”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Apoptosis and Molecular Targeting Therapy in Cancer
Hassan, M. K., Watari, H., Abu-Almaaty, A. H., Ohba, Y., & Sakuragi, N. (2014) · BioMed Research International · doi:10.1155/2014/150845 · Cited by 1,155
RetractedFerroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,332
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Apoptosis, oncosis, and necrosis. An overview of cell death.
Majno, G., & Joris, I. (1995) · PubMed · Cited by 3,328
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Cited by
Sorted by citations
Items 401–500 of 589
Molecular regulation and therapeutic targeting of programmed cell death in hepatocellular carcinoma
Zhao, Y., Yang, L., Wang, P., Huo, S., Yuan, X., & Jiang, J. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156310 · Cited by 4
Che, L., Stevenson, C., Plas, D. R., Wang, J., & Du, C. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08294-5 · Cited by 4
Abdel-Rafei, M. K., Thabet, N. M., Tawel, G. E., Bakary, N. M. E., Fatih, N. M. E., & Azab, K. S. (2021) · Toxin Reviews · doi:10.1080/15569543.2021.2008451 · Cited by 4
The scaffold-dependent function of RIPK1 in experimental non-alcoholic steatohepatitis
Pistorio, V., Tokgozoglu, J., Ratziu, V., & Gautheron, J. (2022) · Journal of molecular medicine · doi:10.1007/s00109-022-02217-z · Cited by 3
Emerging role of regulated cell death in intestinal failure-associated liver disease
Cheng, S., Jiang, L., Wang, Y., & Cai, W. (2022) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2022.12.004 · Cited by 4
Chang, L., Zhang, A., Liu, W., Cao, P., Dong, L., & Gao, X. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.935 · Cited by 3
RetractedLiver Transplantation: A Test of Cellular Physiology, Preservation, and Injury
Martins, B., Mossemann, J., Aguilar, F., Zhao, S., Bilan, P. J., & Sayed, B. A. (2024) · Physiology · doi:10.1152/physiol.00020.2024 · Cited by 4
Zhang, H., He, Y., Zhao, Y., Axinbai, M., Hu, Y., Liu, S., Kong, J., Sun, J., & Zhang, L. (2024) · Hereditas · doi:10.1186/s41065-024-00309-z · Cited by 4
Cheng, H., Wu, J., Peng, H., Li, J., Liu, Z., Wang, X., Zhang, K., & Xie, L. (2024) · Nutrients · doi:10.3390/nu17010106 · Cited by 4
Neodymium nitrate promotes the apoptosis of mouse liver cells via Bcl2l1/Caspase 3 pathway
Leng, J., Wang, N., Chang, X., Zhang, X.-P., Xu, J., Yang, Z., Qian, K.-L., Zheng, Z.-Q., Tao, G., Jia, X., et al. (2025) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2025.2501253 · Cited by 4
Han, L., Yang, J.-R., Zhao, Z., Gao, S., Fan, Y., & Wang, K. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.153147 · Cited by 4
Farooq, M., Eugénio, M. S., Piquet‐Pellorce, C., Dion, S., Raguénès‐Nicol, C., Santamaria, K., Kara-Ali, G. H., Larcher, T., Dimanche‐Boitrel, M., Samson, M., et al. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02192-5 · Cited by 4
Manifold Roles of Ceramide Metabolism in Non-Alcoholic Fatty Liver Disease and Liver Cancer
Wang, K., Wei, Y., Xu, R., Li, Y., & Mao, C. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-0394-6_11 · Cited by 4
Peng, Y.-L., Wang, L., Li, M.-Y., Liu, L., & Li, R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0279744 · Cited by 4
Pedro Ximenez sun-dried grape must: a dietary supplement for a healthy longevity
Morales‐Prieto, N., Huertas-Abril, P. V., de Lerma, N. L., Pacheco, I., Pérez, J., Peinado, R. A., & Abril, N. (2020) · Food & Function · doi:10.1039/d0fo00204f · Cited by 4
How Diet-Induced Changes in the “Gut-Liver” Axis Affect Chronic Liver Disease Outcome?
Koumbi, L., Eliopoulos, A. G., & Vassilopoulou, Ε. (2021) · Livers · doi:10.3390/livers1010004 · Cited by 4
Kaokaen, P., Chaicharoenaudomrung, N., Kunhorm, P., Mesil, K., Binlateh, T., Noisa, P., & Jitprasertwong, P. (2022) · Natural Product Communications · doi:10.1177/1934578x221074838 · Cited by 4
Cross-Shore Sediment Transport Mechanisms in the Surfzone on a Timescale of Months to Years
Houwman, K. T., & Ruessink, G. (1997) · Coastal Engineering Proceedings · doi:10.1061/9780784402429.373 · Cited by 4
Targeting both ferroptosis and pyroptosis may represent potential therapies for acute liver failure
Xing, Z.-Y., Zhang, C., & Liu, L.-J. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i33.3791 · Cited by 4
Barathon, F., Graindorge, P., Bescher, M., Gallais, I., Burel, A., Morel, I., Schroeder, H., Grova, N., Lagadic‐Gossmann, D., & Sergent, O. (2025) · Toxicology · doi:10.1016/j.tox.2025.154184 · Cited by 3
Zhu, Z., Xu, Z., Cao, X., Zhao, N., Lei, J., Li, L., Li, X., Li, Y., Li, M., Ren, T., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101517 · Cited by 3
Wang, Y., Gu, J., Chen, G., Jiang, Y., Xu, Y., Huang, X., Sun, W., & Gan, J. (2025) · Virology Journal · doi:10.1186/s12985-025-02868-7 · Cited by 5
Sun, Z., Liu, H., Xu, Y., Chen, Q., Luo, G., Yuan, Z., Chen, Z., He, K., Fan, C., Li, J., et al. (2025) · Bone Research · doi:10.1038/s41413-025-00463-8 · Cited by 3
Regulated necrosis at the crossroads of liver inflammation and cancer development
Vucur, M., Kondylis, V., Brož, P., & Luedde, T. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01147-8 · Cited by 6
Self-citationRIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitis
Soret, P., Steunou, V., Hedou, J. J., Tokgozoglu, J., Pistorio, V., Majdi, A., Darwane, N., Delaunay, J.-L., Benyahia, S., Dinard, L., et al. (2025) · Science Advances · doi:10.1126/sciadv.adz7907 · Cited by 3
Lian, X., Jiang, J., Yang, Y., Feng, Z., Zhang, X., Yuan, X., & Zhang, P. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.12.019 · Cited by 4
Mao, Y., Huang, L., Long, H., Huang, Q., Kang, F., & Wang, Y. (2026) · Chinese Medicine · doi:10.1186/s13020-026-01369-1 · Cited by 3
Chen, Y., Li, R., Xu, H., & Guo, L. (2024) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh-23-66 · Cited by 3
Tian, L., Sang, Y., Han, B., Sun, Y., Li, X., Feng, Y., Qin, C., & Qi, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34704 · Cited by 3
Hussain, Z. (2025) · Exploration of Digestive Diseases · doi:10.37349/edd.2025.100563 · Cited by 3
Elevated HSP70 Ameliorates Liver Failure Patients via Its Novel Natural Inhibitor
Zhang, Y., Jiang, L., Jiang, Y., Zhu, L., Guo, C., & Zhao, J. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70013 · Cited by 3
Wang, T., Yeh, M. M., Avigan, M., Pelosof, L. C., & Feldman, G. M. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00629-2 · Cited by 4
Sabra, A.-N. A., Salem, M. B., William, S., Hammam, O. A., & El-Lakkany, N. M. (2022) · Experimental Parasitology · doi:10.1016/j.exppara.2022.108293 · Cited by 3
Hepatic interleukin 32 attenuates liver injury through repression of necroptosis in cholestasis
Mao, X. R., Zhang, X., Xu, Z. Q., Zhao, N., Fu, L., Peng, S. F., & Chai, J. (2023) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13196 · Cited by 3
Chen, J., Chen, C., Tao, L., Cai, Y., & Wang, C. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05208-w · Cited by 3
Guizhi Fuling Wan ameliorates concanavalin A-induced autoimmune hepatitis in mice
Kuo, S.-L., Su, C., Lai, K.-H., Chang, Y., You, J., Peng, H., Chen, C., Lin, C., Chen, P., & Hwang, T. (2024) · Biomedical Journal · doi:10.1016/j.bj.2024.100731 · Cited by 3
PSTPIP2 protects against alcoholic liver injury and invokes STAT3-mediated suppression of apoptosis
Yin, N., Chen, X., Sun, Y.-Y., Yang, L., Zhang, Y., Niu, X.-N., Song, H., Huang, C., & Li, J. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116334 · Cited by 3
Regulation of pro-apoptotic and anti-apoptotic factors in obesity-related esophageal adenocarcinoma
Agrawal, S., Podber, A., Gillespie, M., Dietz, N., Hansen, L. A., & Nandipati, K. C. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09931-6 · Cited by 3
Unveiling the nexus: pyroptosis and its crucial implications in liver diseases
Miao, Z., Zhang, X., Xu, Y., Liu, Y., & Yang, Q. F. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05147-1 · Cited by 3
GNF-5837 attenuates acute liver injury by inhibiting oxidative stress
Zhou, X., Luo, X., Huang, Q., Ru, Y., Liu, D., Linghu, M., & Huang, Y. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10522-2 · Cited by 5
Galmiche, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-26780-3_13 · Cited by 3
MODERN VIEWS ON THE FUNCTIONAL MORPHOLOGY AND REPARATIVE PROPERTIES OF THE LIVER
Mustafina, Н. M., Старченко, И. И., Koka, V. М., & Лукачіна, Є. І. (2020) · Bulletin of Problems Biology and Medicine · doi:10.29254/2077-4214-2020-2-156-43-48 · Cited by 4
Yan, C., Liu, C., Wu, Z., Dai, Y., Xia, E., Hu, W., & Dai, X. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.897538 · Cited by 2
Bu, H., Subramanian, S., Chou, P. M., Liu, F., Sun, L., Geng, H., Wang, X., Liao, J., Du, C., Hu, J. K., et al. (2024) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00005.2024 · Cited by 2
Song, X., Li, D., Sun, J., Zhang, X., Wang, L.-S., & Chen, F. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250299 · Cited by 2
Colonna, G. (2024) · Livers · doi:10.3390/livers5010001 · Cited by 3
Wang, J.-F., Shi, K., Xu, Q., Wang, H.-W., Wang, Y.-R., Liu, S.-C., Jiang, W.-J., Chen, R., Chen, Y., Zhang, Y.-D., et al. (2025) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2025.04.045 · Cited by 3
SENP3 protects hepatocyte from pyroptosis during acute liver injury through deSUMOylation of HNRNPL
Xiong, X., Zhi, Y., Yang, N., Zhao, W., Wang, S., Zhu, H., Tang, J. T., Yi, J., Sun, X., & Yang, J. (2025) · iScience · doi:10.1016/j.isci.2025.113067 · Cited by 2
Immune cells in liver regeneration: Current evidence and potential clinical targets
Moore, H. F., Usmani, S., Froghi, S., Rashidi, H., Quaglia, A., Fuller, B. J., & Davidson, B. R. (2025) · International Reviews of Immunology · doi:10.1080/08830185.2025.2531820 · Cited by 4
Yao, Y., Zhang, Y., Xue, B., & Chu, W. (2025) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2025.180328 · Cited by 2
Guo, J., Lin, Y., Gong, X., Kuang, G., Hu, J., Du, H., Liu, H., Zhang, J., Zhang, L., Wan, J.-Y., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05920-5 · Cited by 3
Wu, Z., Zhang, J., Chen, S., Zhou, H., & Liu, Y. (2025) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2026.100313 · Cited by 2
Liu, M., Fu, Q., Zhang, X., You, P., Xiang, M., & Chen, S. (2025) · Shock · doi:10.1097/shk.0000000000002752 · Cited by 2
Ran, M., Yi, R., Zhang, H., Sun, X., Qiu, T., Li, J. N., Wang, N., Yao, X., Zhang, C., Deng, H., et al. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120163 · Cited by 2
Acetylsalicylic acid (Aspirin®) and liver regeneration: experimental study in rats
Biondo-Simões, M. D. L. P., Pessini, V. C. D. A., ICHI, C. A., Robes, R. R., & Ioshii, S. O. (2021) · Revista do Colégio Brasileiro de Cirurgiões · doi:10.1590/0100-6991e-20213164 · Cited by 2
p62 Promotes Survival and Hepatocarcinogenesis in Mice with Liver-Specific NEMO Ablation
Kondylis, V., Schneider, F., Schorn, F., Oikonomou, N., Straub, B. K., Werner, S., Rosenstiel, P. C., & Pasparakis, M. (2022) · Cancers · doi:10.3390/cancers14102436 · Cited by 2
BTF3L4 Overexpression Mediates APAP-induced Liver Injury in Mouse and Cellular Models
Lin, J., Fan, A., Yifu, Z., Xie, Q., Liu, H., & Zhou, W. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00342 · Cited by 2
Kunlayawutipong, T., Apaijai, N., Tepmalai, K., Kongkarnka, S., Leerapun, A., Pinyopornpanish, K., Soontornpun, A., Chattipakorn, S. C., Chattipakorn, N., & Pinyopornpanish, K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27557 · Cited by 2
Donepezil promotes skin flap survival through activation of the HIF ‐1α/ VEGF signalling pathway
Lin, H., Wang, K., Yang, J., Wang, A., Deng, J., & Lin, D. (2024) · Wound Repair and Regeneration · doi:10.1111/wrr.13176 · Cited by 2
Cheng, Y., Rao, P., Li, S., Yu, W., Tang, Y., Wang, R., He, W., & Liu, J. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.117117 · Cited by 2
pisal, H., & Mahajan, A. (2024) · Journal of Preventive Diagnostic and Treatment Strategies in Medicine · doi:10.4103/jpdtsm.jpdtsm_93_24 · Cited by 2
Wang, G., Yin, Y., Lv, R., Ling, X., Cao, H., Liu, H., Wu, J., Gao, Y., Zhang, K., & Wang, Y. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119256 · Cited by 2
Ge, T., Chen, Y., Pang, L., Shao, J., & Chen, Z. (2025) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2300678 · Cited by 2
Programmed cell death and liver diseases
Онищенко, Н. А., Гоникова, З. З., Nikolskaya, A. O., Кирсанова, Л. А., & Sevastianov, V. I. (2022) · Russian Journal of Transplantology and Artificial Organs · doi:10.15825/1995-1191-2022-1-72-88 · Cited by 3
Olowofolahan, A. O., Fatunsin, O., & Olorunsogo, O. O. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02824-8 · Cited by 3
Mathematical modeling of the molecular switch of TNFR1-mediated signaling pathways using Petri netsPreprint
Amstein, L. K., Ackermann, J., Hannig, J., Đikić, I., Fulda, S., & Koch, I. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.02.466901 · Cited by 2
Li, M., Li, J., Ye, L.-H., Ni, L., Huang, X., Liang, X., Zhang, H.-C., Liu, Z., Zhang, X., Li, J., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2958625/v1 · Cited by 2
Xiao, Y., Chen, F., Gao, K., Li, H., Xie, Y., Li, S., Zhang, J., Peng, Q., Zhou, W., Wang, S., et al. (2023) · Engineered Regeneration · doi:10.1016/j.engreg.2023.12.001 · Cited by 1
Positron emission tomography combined with serum biomarkers detects fibrotic MASH
Romeo, S., Chan, C., Matsukuma, K. E., Corwin, M. T., Lyo, V., Chen, S., Wang, G., & Sarkar, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-72655-x · Cited by 1
Huang, Y., Qian, J., Luan, Z., Han, J., & Tang, L. (2025) · Biology · doi:10.3390/biology14050518 · Cited by 1
An Overview of Non-alcoholic Fatty Liver Diseases (NAFLD)
Kang, J., Kim, H.-J., Lim, S.-J., Lee, S., & Hwang, I. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1010672 · Cited by 1
Bhattacharya, I., Arumugam, S., Maity, D. K., Kumar, A., Bhattacharya, T., Sahu, A., & Sreedhar, R. (2025) · MicroRNA · doi:10.2174/0122115366364599250604050335 · Cited by 1
Fan, S., Zhang, Y., Ma, P., Hou, H., Niu, R., Wang, Z., Zhang, J., Xia, Y., & Pan, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1635953 · Cited by 1
Ohene-Marfo, P., Mohammed, S., Jiang, C., Bhaskaran, S., Kneuper, K., Matsuzaki, S., Hagy, B., May, R. J., Georgescu, C., John, M., et al. (2026) · Hepatology · doi:10.1097/hep.0000000000001830 · Cited by 1
Wang, J., Li, Z., Wang, Z., Liang, W., Meng, S., Chen, J.-F., Wang, J., Zhang, J., & Lin, B. (2025) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szaf058 · Cited by 3
Tumour necrosis as a prognostic indicator in hepatocellular carcinoma
Sarelin, N., Kairaluoma, V., Saarnio, J., Kauppila, J. H., Böhm, J., Huhta, H. I., Helminen, O., & Väyrynen, J. P. (2026) · BMC Cancer · doi:10.1186/s12885-026-16040-z · Cited by 1
Role and mechanism of ASGR1 in acute liver injury
Huang, L., Wang, Y., Li, D., Gao, G., Wu, H., Zeng, Y., Zhang, S., Chen, Z., Guo, R., & Chen, R. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.124157 · Cited by 1
Hepatocyte-Derived Apoptotic Bodies as Pathological Intercellular Messengers in the Liver
New‐Aaron, M., Adepoju, L. A., Pathania, A. S., Kharbanda, K. K., & Osna, N. A. (2026) · Biomolecules · doi:10.3390/biom16020198 · Cited by 2
Alqahtani, M. J., El-Sherbeni, S. A., Negm, W. A., Elekhnawy, E., Ibrahim, S. A., Hussein, I. A., Alanzi, A. R., Ahmed, R., Balaha, M. F., & El-Kadem, A. H. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122017 · Cited by 1
Hu, M.-Y., Hou, X.-Y., Huang, X.-S., Yu, X.-L., Liu, F., & Yang, J. (2026) · Toxics · doi:10.3390/toxics14070625 · Cited by 1
Azzam, S. M., Straus, A. J., Senkal, C. E., & Sarkar, D. (2026) · Cancers · doi:10.3390/cancers18142335 · Cited by 1
Dronov, O. I., Kovalska, I. O., Kozachuk, Y. S., Levchenko, L. V., Vlasenko, D. А., & Shvets, A. S. (2023) · Wiadomości Lekarskie · doi:10.36740/wlek202303115 · Cited by 1
Weighted Gene Co-Expression Network Iden-tifying Core Nonalcoholic Fatty Liver Disease Genes
马, 博. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1371703 · Cited by 1
Pomacu, M. M., Trașcă, D.-M., Pădureanu, V., Stănciulescu, E. C., Busuioc, C. J., Pisoschi, C. G., & Bugă, A. M. (2023) · PubMed Central · doi:10.12865/chsj.49.01.54 · Cited by 1
An Apoptotic Gene Signature for the Prognosis of Hepatocellular Carcinoma
Chen, K., Zhu, P., Liao, Y., Yan, L., Feng, R., & Zhai, W. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s293610 · Cited by 1
Land, W. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53868-2_9 · Cited by 1
Ocimum gratissimum as a Remedy to Chemical Induced Liver Injury
Ajani, R. S., & Obasa, G. K. (2022) · Journal of Complementary and Alternative Medical Research · doi:10.9734/jocamr/2022/v18i330354 · Cited by 1
From fatty liver to nonalcoholic steatohepatitis with fibrosis
Muriel, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99764-5.00013-5 · Cited by 1
Shi, H., Wang, X., Gerlach, B. D., Yurdagul, A., Moore, M. P., Mirshahi, F., Ronzoni, L., Sanyal, A. J., Valenti, L. V. C., Lin, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.30.578023 · Cited by 1
Microbial Peptidoglycan Engages Autophagy Receptor P62 to Induce Protective Mitophagy in the LiverPreprint
Tie, J., Wang, L., Wang, X., Tian, M., Lu, W., Qi, B., & Shan, Z. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.27.662070 · Cited by 1
Flavones as Potential Adjuvants for Therapeutic Treatments of Hepatocellular Carcinoma
Wu, R. P. (2020) · Advanced Research in Gastroenterology & Hepatology · doi:10.19080/argh.2020.15.555907
Jiao, L. R., Eickhoff, R., Jumpertz, S., Roth, J., Erdem, M., Kroh, A., Duimel, H., López‐Iglesias, C., Schmeding, M., Heij, L. R., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.06.239426
An apoptosis-related gene signature for the prognosis of hepatocellular carcinomaPreprint
Zhu, P., Zhang, L., Zhicheng, D., Yuan, L., Lei, Y., Wenlong, Z., & Chen, K. (2020) · doi:10.21203/rs.3.rs-19086/v1
Chen, J., Wang, H., Zhou, L., Liu, Z., Chen, H., & Tan, X. (2022) · Research Square · doi:10.21203/rs.3.rs-1201594/v1
Aliseda, D., Cienfuegos, J. A., Valentí, V., Echeveste, J. I., Luján, J., de Almeida, A. P. O. B., & Rotellar, F. (2022) · ANZ Journal of Surgery · doi:10.1111/ans.17373
Ishtiaq, S. M., Arshad, M. I., & Khan, J. A. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4192515
Trapeznikova, E. G., & Шилов, В. В. (2022) · Russian Journal of Occupational Health and Industrial Ecology · doi:10.31089/1026-9428-2022-62-11-761-766
Recent Updates in the Prevention of Nonalcoholic Fatty Liver Disease
El‐Kassas, M., Awad, A., & Méndez‐Sánchez, N. (2023) · Gene Expression · doi:10.14218/ge.2022.00005s
Bệnh gan nhiễm mỡ liên quan chuyển hóa (MAFLD): bệnh hệ thống ngoài gan
Minh, H. Đ. L., & Tuong, T. T. K. (2023) · Pham Ngoc Thach Journal of Medicine and Pharmacy · doi:10.59715/pntjmp.2.1.1
dược, P. Y. (2023) · Pham Ngoc Thach Journal of Medicine and Pharmacy · doi:10.59715/pntjmp.2.1.0
Metadata
- Authors
- Schwabe, R. F., & Luedde, T.
- Affiliations
- Columbia University Irving Medical Center (US)
- Universitätsklinikum Aachen (DE)
- Corresponding author
- Schwabe, Robert F.
- Luedde, Tom
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2018-09-24
- Volume
- 15
- Issue
- 12
- Pages
- 738-752
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- PMC
- PMC6490680
- OpenAlex
- W2890337997
- Cited by
- 582
- References
- 185
- Citations by year
- 2026: 51 · 2025: 82 · 2024: 93 · 2023: 91 · 2022: 94 · 2021: 78 · 2020: 59 · 2019: 33
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (U01AA021912)
- National Cancer Institute (R01CA190844, R01CA200597)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK116620)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- apoptosis, necroptosis, programmed cell death, liver injury, acute liver failure, chronic liver disease, liver fibrosis, liver cirrhosis, liver cancer, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, hepatic stellate cells, hepatocyte turnover, cell death detection
- MeSH terms
- Animals, Humans, Liver, Liver Diseases, Necrosis, Cell Death, Apoptosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review